MDD Clinical Trial - Effect of Short-Term Mindfulness-Based Training For

See also
Status	Clinical Trial	Phase
Completed	`NCT04482296` - Effect of Zinc Supplementation on Depression in SSRI-treated Major Depressive Disorder Patients	N/A
Completed	`NCT04076644` - Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder	N/A
Completed	`NCT05528315` - SAD/MAD of ABX-002-1902 Investigating the Safety, Pharmacokinetics/Pharmacodynamics of in Healthy Subjects	Phase 1
Recruiting	`NCT05437588` - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents	N/A
Recruiting	`NCT06095778` - rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS	N/A
Active, not recruiting	`NCT05657691` - Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)	Phase 2
Completed	`NCT02013609` - Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment	Phase 3
Completed	`NCT02339285` - Transcranial Alternating Current Stimulation for Major Depressive Disorder	N/A
Recruiting	`NCT03971305` - A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL
Recruiting	`NCT05169346` - Neurofeedback to Treat Depression	N/A
Completed	`NCT01344733` - A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)	N/A
Completed	`NCT04268316` - Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder	N/A
Active, not recruiting	`NCT01557946` - Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression	Phase 2
Recruiting	`NCT01501812` - Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders	N/A
Completed	`NCT04880460` - Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients	Phase 2
Completed	`NCT04226352` - Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder	Phase 1
Recruiting	`NCT03754712` - Effect of Vitamin D Administration Along With SSRIs in Patients With Major Depressive Disorder	N/A
Recruiting	`NCT02669030` - A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia	Phase 4
Completed	`NCT03994081` - Mechanism of Action of tACS for the Treatment of MDD	N/A
Completed	`NCT01152554` - A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder	Phase 3

NCT number	NCT04071886
Study type	Interventional
Source	Central South University
Contact	Li Lingjiang, MD Ph.D
Phone	+86 13807314575
Email	LLJ2920@csu.edu.cn
Status	Recruiting
Phase	N/A
Start date	September 1, 2019
Completion date	January 2020

Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms